Lim S, Lee SH, Min KW, Lee CB, et al. A multicentre, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin. Diabetes Obes Metab 2024 Feb 29. doi: 10.1111/dom.15526.
PMID: 38425186